- Home
- SPOK vs QSI Comparison
SPOK vs QSI Comparison
Compare SPOK & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPOK
- QSI
- Stock Information
- Founded
- SPOK 2004
- QSI 2013
- Country
- SPOK United States
- QSI United States
- Employees
- SPOK 406
- QSI N/A
- Industry
- SPOK Telecommunications Equipment
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- SPOK Telecommunications
- QSI Health Care
- Exchange
- SPOK Nasdaq
- QSI Nasdaq
- Market Cap
- SPOK 329.2M
- QSI 284.0M
- IPO Year
- SPOK 1992
- QSI N/A
- Fundamental
- Price
- SPOK $16.35
- QSI $1.28
- Analyst Decision
- SPOK Hold
- QSI Buy
- Analyst Count
- SPOK 1
- QSI 2
- Target Price
- SPOK $15.00
- QSI $3.25
- AVG Volume (30 Days)
- SPOK 88.6K
- QSI 31.8M
- Earning Date
- SPOK 10-30-2024
- QSI 11-12-2024
- Dividend Yield
- SPOK 7.70%
- QSI N/A
- EPS Growth
- SPOK N/A
- QSI N/A
- EPS
- SPOK 0.71
- QSI N/A
- Revenue
- SPOK $137,714,000.00
- QSI $2,266,000.00
- Revenue This Year
- SPOK $2.45
- QSI $193.90
- Revenue Next Year
- SPOK $0.80
- QSI $173.18
- P/E Ratio
- SPOK $22.91
- QSI N/A
- Revenue Growth
- SPOK N/A
- QSI 232.26
- 52 Week Low
- SPOK $13.24
- QSI $0.61
- 52 Week High
- SPOK $18.14
- QSI $2.58
- Technical
- Relative Strength Index (RSI)
- SPOK 59.68
- QSI 48.50
- Support Level
- SPOK $16.51
- QSI $0.61
- Resistance Level
- SPOK $16.86
- QSI $2.58
- Average True Range (ATR)
- SPOK 0.26
- QSI 0.34
- MACD
- SPOK -0.01
- QSI -0.03
- Stochastic Oscillator
- SPOK 77.93
- QSI 13.33
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. It reports three market segments namely Healthcare, Government, and Large enterprise. The company provides paging services and software solutions in the United States and abroad. It provides services such as Value-Added Services, Advisory Services, Assessment Services and Adoption Services.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.